High expression of karyopherin-α2 defines poor prognosis in non-muscle-invasive bladder cancer and in patients with invasive bladder cancer undergoing radical cystectomy

European Urology

Volumn 59, Issue 5, 2011, Pages 841-848

  Jensen, Jørgen Bjerggaard ^a   Munksgaard, Pia Pinholt ^a   Sørensen, Christoffer Mørk ^a   Fristrup, Niels ^a   Birkenkamp Demtroder, Karin ^a   Ulhøi, Benedicte Parm ^a   Jensen, Klaus Møller Ernst ^a   Ørntoft, Torben F ^a   Dyrskjøt, Lars ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Biomarker; Bladder cancer; KPNA2; Prognostic marker; Radical cystectomy; Tissue microarray; TMA; Urothelial carcinoma

Indexed keywords

KARYOPHERIN ALPHA; KARYOPHERIN ALPHA2; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER INVASION; CANCER RECURRENCE; CANCER RISK; CYSTECTOMY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TISSUE MICROARRAY;

ADULT; AGED; AGED, 80 AND OVER; ALPHA KARYOPHERINS; ANIMALS; BLOTTING, WESTERN; CELL LINE, TUMOR; CERCOPITHECUS AETHIOPS; COS CELLS; CYSTECTOMY; DENMARK; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; RISK FACTORS; SURVIVAL RATE; TIME FACTORS; TISSUE ARRAY ANALYSIS; TRANSFECTION; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION; URINARY BLADDER NEOPLASMS;

EID: 79953233320     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2011.01.048     Document Type: Article

References (29)

1. M.M. Knap, F. Lundbeck, and J. Overgaard Prognostic factors, pattern of recurrence and survival in a Danish bladder cancer cohort treated with radical cystectomy Acta Oncol 42 2003 160 168 (Pubitemid 36570781)
2. B.W.G. van Rhijn, M. Burger, and Y. Lotan Recurrence and progression of disease in non-muscle-invasive bladder cancer: from epidemiology to treatment strategy Eur Urol 56 2009 430 442
3. M. Sanchez-Carbayo, N.D. Socci, J. Lozano, F. Saint, and C. Cordon-Cardo Defining molecular profiles of poor outcome in patients with invasive bladder cancer using oligonucleotide microarrays J Clin Oncol 24 2006 778 789 (Pubitemid 46622045)
4. L. Dyrskjot, K. Zieger, and F.X. Real Gene expression signatures predict outcome in non-muscle-invasive bladder carcinoma: a multicenter validation study Clin Cancer Res 13 2007 3545 3551 (Pubitemid 46955114)
5. D. Theodorescu, L.M. Sapinoso, M.R. Conaway, G. Oxford, G.M. Hampton, and H.F. Frierson Jr. Reduced expression of metastasis suppressor RhoGDI2 is associated with decreased survival for patients with bladder cancer Clin Cancer Res 10 2004 3800 3806 (Pubitemid 38697615)
6. S.F. Tseng, C.Y. Chang, K.J. Wu, and S.C. Teng Importin KPNA2 is required for proper nuclear localization and multiple functions of NBS1 J Biol Chem 280 2005 39594 39600
7. L. Zannini, D. Lecis, and S. Lisanti Karyopherin-alpha2 protein interacts with Chk2 and contributes to its nuclear import J Biol Chem 278 2003 42346 42351 (Pubitemid 37310504)
8. S.C. Teng, K.J. Wu, S.F. Tseng, C.W. Wong, and L. Kao Importin KPNA2, NBS1, DNA repair and tumorigenesis J Mol Histol 37 2006 293 299 (Pubitemid 44795632)
9. L. Dyrskjot, M. Kruhoffer, and T. Thykjaer Gene expression in the urinary bladder: a common carcinoma in situ gene expression signature exists disregarding histopathological classification Cancer Res 64 2004 4040 4048 (Pubitemid 38697320)
10. F.L. Egerod, A. Bartels, and N. Fristrup High frequency of tumor cells with nuclear Egr-1 protein expression in human bladder cancer is associated with disease progression BMC Cancer 9 2009 385
11. J.N. Eble, G. Sauter, J.I. Epstein, I.A. Sesterhenn, WHO classification of tumours: pathology and genetics of tumours of the urinary system and male genital organs 2004 International Agency for Research on Cancer Press Lyon, France
12. R.J. Sylvester, A.P.M. van der Meijden, and W. Oosterlinck Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials Eur Urol 49 2006 466 477
13. J.B. Jensen, B.P. Ulhoi, and K.M. Jensen Lymph node mapping in patients with bladder cancer undergoing radical cystectomy and lymph node dissection to the level of the inferior mesenteric artery BJU Int 106 2010 199 205
14. E. Dahl, G. Kristiansen, and K. Gottlob Molecular profiling of laser-microdissected matched tumor and normal breast tissue identifies karyopherin alpha2 as a potential novel prognostic marker in breast cancer Clin Cancer Res 12 2006 3950 3960 (Pubitemid 44078080)
15. A. Dankof, F.R. Fritzsche, and E. Dahl KPNA2 protein expression in invasive breast carcinoma and matched peritumoral ductal carcinoma in situ Virchows Arch 451 2007 877 881 (Pubitemid 350060752)
16. O. Gluz, P. Wild, and R. Meiler Nuclear karyopherin alpha2 expression predicts poor survival in patients with advanced breast cancer irrespective of treatment intensity Int J Cancer 123 2008 1433 1438
17. V. Margulis, S.F. Shariat, R. Ashfaq, A.I. Sagalowsky, and Y. Lotan Ki-67 is an independent predictor of bladder cancer outcome in patients treated with radical cystectomy for organ-confined disease Clin Cancer Res 12 2006 7369 7373 (Pubitemid 46095410)
18. V. Margulis, Y. Lotan, and P.I. Karakiewicz Multi-institutional validation of the predictive value of Ki-67 labeling index in patients with urinary bladder cancer J Natl Cancer Inst 101 2009 114 119
19. F.E. Harrell Jr., R.M. Califf, D.B. Pryor, K.L. Lee, and R.A. Rosati Evaluating the yield of medical tests JAMA 247 1982 2543 2546 (Pubitemid 12155954)
20. F.E. Harrell Jr., K.L. Lee, and D.B. Mark Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors Stat Med 15 1996 361 387 (Pubitemid 26072233)
21. S. Thakur, H.B. Zhang, and Y. Peng Localization of BRCA1 and a splice variant identifies the nuclear localization signal Mol Cell Biol 17 1997 444 452 (Pubitemid 26425634)
22. Wang CI, Wang CL, Wang CW, et al. Importin subunit alpha-2 is identified as a potential biomarker for non-small cell lung cancer by integration of the cancer cell secretome and tissue transcriptome. Int J Cancer. In press. doi:10.1002/ijc.25568.
23. Y. Wang, J.G. Klijn, and Y. Zhang Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer Lancet 365 2005 671 679 (Pubitemid 40260888)
24. M. Zheng, L. Tang, and L. Huang Overexpression of karyopherin-2 in epithelial ovarian cancer and correlation with poor prognosis Obstet Gynecol 116 2010 884 891
25. M. Sakai, M. Sohda, and T. Miyazaki Significance of karyopherin-{alpha} 2 (KPNA2) expression in esophageal squamous cell carcinoma Anticancer Res 30 2010 851 856
26. V. Winnepenninckx, V. Lazar, and S. Michiels Gene expression profiling of primary cutaneous melanoma and clinical outcome J Natl Cancer Inst 98 2006 472 482
27. P.P. Dangle, M.C. Gong, R.R. Bahnson, and K.S. Pohar How do commonly performed lymphadenectomy templates influence bladder cancer nodal stage? J Urol 183 2010 499 503
28. S.F. Shariat, Y. Lotan, and A. Vickers Statistical consideration for clinical biomarker research in bladder cancer Urol Oncol 28 2010 389 400
29. C. Hafner, R. Knuechel, R. Stoehr, and A. Hartmann Clonality of multifocal urothelial carcinomas: 10 years of molecular genetic studies Int J Cancer 101 2002 1 6 (Pubitemid 34832989)